Clinical Trial Update: Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation [Phase 1]

View source ↗

Summary

Phase I study evaluating eltrombopag to boost platelet production after total body irradiation; the trial has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Syndrome
• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Jane Liesveld | Conditions: Thrombocytopenia, Acute Radiation Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2016-05-05